bluebird bio, Inc.

NasdaqGS:BLUE Stock Report

Market Cap: US$82.6m

bluebird bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BLUE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Dec 24SellUS$405Andrew ObenshainIndividual48.55US$8.35
10 Dec 24SellUS$1,178Richard ColvinIndividual141.2US$8.35
30 Sep 24SellUS$529Thomas KlimaIndividual50.3US$10.51
30 Sep 24SellUS$18,270Andrew ObenshainIndividual1,739US$10.51
03 Jun 24SellUS$3,726Thomas KlimaIndividual191.7US$19.44
04 Mar 24SellUS$6,986Thomas KlimaIndividual228.65US$30.55
04 Mar 24SellUS$9,311Andrew ObenshainIndividual304.75US$30.55
01 Mar 24SellUS$10,342Richard ColvinIndividual338.5US$30.55
05 Feb 24SellUS$4,708Joseph VittiglioIndividual260.85US$18.05
05 Feb 24SellUS$2,449Thomas KlimaIndividual135.7US$18.05
05 Feb 24SellUS$1,696Andrew ObenshainIndividual93.95US$18.05
05 Jan 24SellUS$845Richard ColvinIndividual29.85US$28.30
05 Jan 24SellUS$4,520Andrew ObenshainIndividual158.1US$28.59

Insider Trading Volume

Insider Buying: BLUE insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BLUE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders45,3710.467%
Institutions3,160,80532.5%
General Public6,516,04167%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 28.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.94%
BlackRock, Inc.
772,188US$6.6m0.01%no data
5.39%
The Vanguard Group, Inc.
523,700US$4.5m1.68%no data
2.41%
Geode Capital Management, LLC
234,152US$2.0m3.69%no data
1.98%
State Street Global Advisors, Inc.
192,096US$1.6m1.14%no data
1.28%
FMR LLC
124,098US$1.1m8.71%no data
0.84%
Avidity Partners Management, L.P.
81,557US$693.2k0%0.04%
0.83%
Millennium Management LLC
80,439US$683.7k-68.7%no data
0.81%
Lion Point Capital, LP
78,912US$670.8k133%3.12%
0.79%
Northern Trust Global Investments
76,792US$652.7k-4.92%no data
0.67%
ExodusPoint Capital Management, LP
64,833US$551.1k0%0.01%
0.54%
Renaissance Technologies LLC
52,908US$449.7k33.7%no data
0.5%
Masters Capital Management, L.L.C.
48,750US$414.4k0%0.09%
0.5%
Morgan Stanley, Investment Banking and Brokerage Investments
48,284US$410.4k88.9%no data
0.43%
Bank of America Corporation, Asset Management Arm
42,187US$358.6k3.65%no data
0.37%
Two Sigma Advisers, LP
35,655US$303.1k-15.7%no data
0.35%
AQR Capital Management, LLC
33,843US$287.7k-49.2%no data
0.31%
Palo Alto Investors LP
30,213US$256.8k-87%0.04%
0.31%
Dimensional Fund Advisors LP
30,193US$256.6k-19.3%no data
0.3%
BNY Asset Management
28,951US$246.1k-15.6%no data
0.29%
Merrill Lynch & Co. Inc., Banking Investments
28,399US$241.4k21.8%no data
0.29%
Summit X
28,391US$241.3k-2.51%0.06%
0.28%
Charles Schwab Investment Management, Inc.
27,653US$235.0k-0.2%no data
0.28%
Susquehanna International Group, LLP, Asset Management Arm
27,081US$230.2k-40%no data
0.26%
JP Morgan Asset Management
25,746US$218.8k-3.37%no data
0.23%
Nick Leschly
22,757US$193.4k-0.42%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 18:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

bluebird bio, Inc. is covered by 34 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Huidong WangBarclays
Zhiqiang ShuBerenberg